MEDCAW INVESTMENTS LS-01 Market Cap ($362.25K)
Market Cap & Net Worth: MEDCAW INVESTMENTS LS-01 (U09)
MEDCAW INVESTMENTS LS-01 market cap. MEDCAW INVESTMENTS LS-01 (F:U09) has a market capitalization of $362.25K (€309.85K) as of November 3, 2026. Listed on the F stock exchange, this Germany-based company holds position #31189 globally and #2755 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MEDCAW INVESTMENTS LS-01's stock price €0.01 by its total outstanding shares 22132095 (22.13 Million).
MEDCAW INVESTMENTS LS-01 Market Cap History (2023–2026)
MEDCAW INVESTMENTS LS-01 market cap history from 2023 to 2026. Data shows change from $1.05 Million to $362.25K (-42.01% CAGR). Check today's stock price for MEDCAW INVESTMENTS LS-01 for real-time trading data and today's change.
MEDCAW INVESTMENTS LS-01 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MEDCAW INVESTMENTS LS-01's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of U09 by Market Capitalization
Companies near MEDCAW INVESTMENTS LS-01 in the global market cap rankings as of November 3, 2026.
Key companies related to MEDCAW INVESTMENTS LS-01 by market ranking:
- BlackRock Inc (NYSE:BLK): Ranked #134 globally with a market cap of $167.86 Billion USD.
- Brookfield Corporation (TO:BN): Ranked #275 globally with a market cap of $94.09 Billion USD ( CA$130.07 Billion CAD).
- Blackstone Group Inc (NYSE:BX): Ranked #288 globally with a market cap of $90.42 Billion USD.
- KKR & Co. Inc. (NYSE:KKR): Ranked #303 globally with a market cap of $87.98 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #134 | BlackRock Inc | NYSE:BLK | $167.86 Billion | $1167.15 |
| #275 | Brookfield Corporation | TO:BN | $94.09 Billion | CA$57.95 |
| #288 | Blackstone Group Inc | NYSE:BX | $90.42 Billion | $120.14 |
| #303 | KKR & Co. Inc. | NYSE:KKR | $87.98 Billion | $98.01 |
Market Capitalization of MEDCAW INVESTMENTS LS-01 (2023–2026)
Market capitalization of MEDCAW INVESTMENTS LS-01 from 2023 to today. Between 2023 and today, MEDCAW INVESTMENTS LS-01's market cap moved from $1.05 Million to $ 362.25K, with a yearly change of -42.01%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €362.25K | -49.09% |
| 2025 | €711.56K | -32.10% |
| 2024 | €1.05 Million | 0.00% |
| 2023 | €1.05 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of MEDCAW INVESTMENTS LS-01 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $362.25K USD |
| MoneyControl | $362.25K USD |
| MarketWatch | $362.25K USD |
| marketcap.company | $362.25K USD |
| Reuters | $362.25K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About MEDCAW INVESTMENTS LS-01
Medcaw Investments Plc does not have significant operations. It focuses on identifying acquisition opportunities. The company was incorporated in 2020 and is based in London, the United Kingdom.